Usage: Promethazine hydrochloride tablets are indicated for allergic rhinitis, allergic conjunctivitis, skin allergies, and adjunct therapy in anaphylactic reactions. They provide sedation for preoperative and postoperative procedures, control nausea and vomiting, and treat motion sickness. They also assist with pain relief when used alongside analgesics.
Usage: Propofol injectable emulsion is indicated for inducing and maintaining general anesthesia in patients aged 2 months and older, monitored anesthesia care sedation in adults, sedation with regional anesthesia, and ICU sedation for intubated, mechanically ventilated adults. It is not recommended for pediatric use under 2 months.
Usage: Propofol injectable emulsion is an intravenous general anesthetic indicated for inducing and maintaining general anesthesia in patients 3 years and older, maintaining anesthesia in patients over 2 months, providing monitored anesthesia care in adults, and sedation for intubated, mechanically ventilated adults in ICU.
Usage: Propofol injectable emulsion is indicated for induction and maintenance of general anesthesia in patients aged 3 years and older, monitored anesthesia care (MAC) sedation in adults, sedation with regional anesthesia in adults, and ICU sedation for intubated and mechanically ventilated adults.
Usage: Propofol injectable emulsion is indicated for induction and maintenance of general anesthesia in patients aged 3 years and older, monitored anesthesia care (MAC) sedation in adults, and ICU sedation of intubated adults. Safety and effectiveness are not established in patients younger than 3 years or for pediatric MAC sedation and ICU use.